Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Amgen
 More »

  • Scaleup Issues for Single Use and Steel
    ... Dr. Greller mentioned the work of Matthew Hammond and his coworkers at Amgen, who have identified one of the most toxic extractable compounds from a number of substances present in ...
    10-15-2013
  • Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology
    ImmunoGen said it has four wholly owned clinical-stage product candidates and additional compounds in clinical phases through collaborations with Amgen, Bayer HealthCare, Biotest, ...
    10-11-2013
  • Ovarian Cancer Treatment Options Multiply
    ... Avastin® by Roche/Genentech/Chugai and trebananib by Amgen were cited as leading contenders. Amgen's trebananib is in Phase III trials. This investigational peptibody-a hybrid ...
    10-8-2013
  • Young Companies in the Money: 25 Firms to Watch
    ... and Seroba Kernel Life Sciences; and new investors Sunstone Capital, Baxter Ventures, Amgen Ventures, and EMBL Ventures #14. Effector Therapeutics Amount: $45 million Type: Series ...
    10-2-2013
  • Amgen Plans R&D Center in China
    Amgen plans to open an R&D center at ShanghaiTech University as part of a new strategic ... Under a memorandum of understanding signed by both, Amgen will co-locate its China R&D ...
    9-25-2013
  • Takeover Targets: Who Is First on the List?
    Targets after Onyx Pharmaceutical Rejects Amgen? " July-One of 10 companies cited by Cowen ... Targets after Onyx Pharmaceutical Rejects Amgen? " July-One of 10 companies cited by Cowen ...
    9-24-2013
  • Top 40 Molecular Millionaires
    ... on December 1) #26. Robert A. Bradway Chairman of the Board, President and CEO, Amgen Total value of all shares: $77,802,615 23 436,728 shares of common stock and 366,935 ...
    9-19-2013
  • Empire Crumbles for a Once Biotech King
    ... Yet, Blech went on to help to start Ariad Pharmaceuticals, Alexion Pharmaceuticals and, with the late George Rathmann of Amgen fame, Icos, which developed Cialis. What was the ...
    9-18-2013
  • Progress in Protein Expression Technology
    ... scientists at Amgen have developed an assay to identify recombinant immunoglobulin clones that are predisposed to aggregation. [Used with permission of Amgen Inc.] Recombinant ...
    9-15-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    Amgen-Onyx, Perrigo-Elan warm an M&A space that had been chilled by an IPO revival. ... Amgen-Onyx is also the largest deal to date in the second half of 2013. This period, ...
    9-9-2013
  • Baxter, Coherus Ink Biosimilar Collaboration Worth Up to $246M
    Amgen in the United States and Canada under an agreement with Pfizer set to expire Oct. 31. Last year the drug racked up $7.963 billion in sales, including $4.236 billion by Amgen ...
    9-3-2013
  • Top Biotech & Pharma Companies
    This compares to 11 companies raising $771 million during the same period a year ago. Earlier this year, Burrill pointed out that Big Biotech firms (e.g., Amgen, Gilead Sciences, ...
    9-1-2013
  • Spreading Sunshine on What Biopharma Pays Physicians
    ... ProPublica has tallied more than $2 billion from 15 biopharmas since 2009. Until the Sunshine Act, some drug giants including Amgen, Bayer, Sanofi, and Roche disclosed no payment ...
    8-29-2013
  • Amgen Grows Cancer Holdings with $10.4B Onyx Acquisition
    Amgen ended weeks of speculation in biopharma circles yesterday when it said it plans to ... The boards of both Amgen and Onyx have approved the deal, which is still subject to ...
    8-26-2013
  • Array Lays Off 50 after Amgen Diabetes Collaboration Ends
    it "received notification this week that Amgen has elected to end its glucokinase ... The partnership's end and the job cuts come 3-1/2 years after Array and Amgen announced ...
    8-8-2013

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll